Century Therapeutics (IPSC) Other financing activities (2020 - 2021)
Century Therapeutics' (IPSC) quarterly Other financing activities came in at $219.1 million in Q3 2021, up 164652.63% year-on-year from N/an in Q3 2020, and up 12587.96% on a QoQ basis from $1.7 million in Q2 2021.
Century Therapeutics (IPSC) Other financing activities (2020 - 2021) Analysis & Trends
Century Therapeutics (IPSC) has 2 years of Other financing activities data on file, last reported at $219.1 million in Q3 2021.
- On a quarterly basis, Other financing activities rose 164652.63% year-over-year to $219.1 million in Q3 2021; TTM through Dec 2021 was $221.4 million, a N/A change from a year earlier, with the FY2021 full-year figure at $221.4 million, up 153651.39% from the prior year.
- Other financing activities for Q3 2021 stood at $219.1 million, up from $1.7 million in the prior quarter.
- Over the last five years, Other financing activities for IPSC reached as high as $219.1 million in Q3 2021 and fell as low as $133000.0 in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Century Therapeutics | 419.84 Mn | 285.04 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 219.12 Mn |
| Sep 30, 2021 | 219.12 Mn |
| Jun 30, 2021 | 1.73 Mn |
| Jun 30, 2021 | 1.73 Mn |
| Mar 31, 2021 | 554,000.00 |
| Mar 31, 2021 | 554,000.00 |
| Sep 30, 2020 | 133,000.00 |
| Sep 30, 2020 | 133,000.00 |